ENहिन्दी soon
Home/India/Answers/Can you take metformin and Ozempic together?
INIndia Diabetes

Can you take metformin and Ozempic together?

GLP Guidebook teamUpdated 5 Oct 20269 sourcesWritten from published sources
The short answer

Yes, metformin and Ozempic (semaglutide) are a studied, guideline-listed combination. India's RSSDI 2022 guideline lists GLP-1 medicines, Ozempic's class, as a second step after metformin. The US Ozempic label advises no metformin dose change. Vomiting or diarrhoea can dehydrate you, which the US Ozempic label links to kidney injury. Lows are likelier with insulin or a sulfonylurea.

Before you go further
  • GLP‑1 medicines are prescription-only in India, not sold over the counter.1
  • A government statement on 1 Apr 2026 said only endocrinologists, internal-medicine specialists and cardiologists can prescribe them.1 CDSCO expert-committee minutes attach a similar condition to some approvals (endocrinologist or internal-medicine specialist), but we found no rule covering every brand.2
  • The risks are in Guide 5: Side effects and risks.
  • Nothing here promises any result.

Does Ozempic interact with metformin?

The US Ozempic label lists metformin as needing no dose adjustment, based on tests of metformin levels in the blood with and without semaglutide.3

Ozempic slows how fast the stomach empties, so the label still asks for caution with any tablet taken by mouth.3

India's RSSDI 2022 guideline starts metformin at diagnosis, unless it is unsuitable or not tolerated. It lists GLP‑1 medicines, Ozempic's class, as a second step in overweight or obesity when metformin is not enough.6

In the US label, 5 of the 6 Ozempic blood-sugar trials included people already on metformin.3 In one of those trials, SUSTAIN 2, 94% of 1,231 people took metformin. Over 56 weeks, HbA1c (average blood sugar) fell 1.3 percentage points on Ozempic 0.5 mg and 1.5 on 1 mg. It fell 0.7 on the tablet sitagliptin.3 Weight fell 4.2 and 5.5 kg, against 1.7 kg.3 Ozempic's maker, Novo Nordisk, funded it.4

RisksThe risks, in brief
  • Stopping because of side effects. In SUSTAIN 2, 8% to 10% on Ozempic stopped because of side effects (adverse events), vs 3% on sitagliptin.4
  • Dehydration and kidneys. Vomiting or diarrhoea can dry you out. The US Ozempic label reports kidney injury from this.3 The US metformin label says kidney problems and dehydration raise the risk of lactic acidosis.5
  • Pancreatitis (a swollen pancreas) has been seen. The US label says to stop if it is suspected.3
  • Hypos are more likely with a sulfonylurea or insulin.3
  • Thyroid. Ruled out by the US label for anyone with a personal or family history of medullary thyroid cancer or MEN 2; tell your doctor if this applies.3
Full detail in Guide 5: Side effects and risks →

Do the stomach side effects add up?

Both medicines most often cause stomach side effects, and adding Ozempic to metformin brought more of them in SUSTAIN 2.4,5

In that trial, 18% on Ozempic felt sick (nausea), against 7% on sitagliptin. Loose stools (diarrhoea) affected 13%, against 7%.4 Most nausea, vomiting and diarrhoea on Ozempic came while the dose was being stepped up.3

Metformin brings its own. In a 29-week US label trial, 53% on metformin had diarrhoea, against 12% on a dummy tablet.5 The American Diabetes Association (ADA) says slow dose increases, extended-release tablets and taking metformin with food can ease this.7 More is in Nausea on a GLP‑1.

Fluid loss matters with this pair. The US Ozempic label reports kidney injury, sometimes needing dialysis, mostly in people dehydrated by nausea, vomiting or diarrhoea.3 The US metformin label counts kidney problems as a risk for lactic acidosis, a serious acid build-up. Its patient guide adds dehydration.5

Does the pair cause low blood sugar?

In SUSTAIN 2, where almost all took metformin, few had a low (hypo), but insulin or a sulfonylurea such as glimepiride raises the risk.3,4

Ozempic releases insulin mainly when blood sugar is high.3 In that trial, a confirmed low happened in 2% or fewer on Ozempic, and 1% on sitagliptin.4

With a sulfonylurea, severe lows reached 0.8% to 1.2% on Ozempic.3 Both labels say the insulin or sulfonylurea dose may need lowering.3,5 See Can GLP‑1 medicines cause low blood sugar? and the “GLP 1mg” tablet.

Get help now: call 112 if someone with diabetes becomes confused, passes out, or a low is not getting better with treatment. The ADA calls a severe low an emergency.9
On metformin and asked about Ozempic?

Build a list of questions for your doctor. Free, no sign-up.

Make my list

Why check vitamin B12 on long-term metformin?

Metformin, not Ozempic, can lower vitamin B12 over time, so the ADA's 2026 standards suggest checking it now and then.8

The ADA puts it most strongly for people with anaemia or nerve damage (neuropathy).8 It also flags doses of 1,500 mg a day or more, and 4 to 5 years of use.8 After 4 years, or with a vegan diet, it suggests a yearly check.8

In 29-week trials in the US metformin label, B12 dropped below normal in about 7% of people. It recovered with stopping metformin or taking B12.5 We found no mention of B12 in the US Ozempic label.3 The type 2 diabetes path covers the other checks.

Read the full picture

Related questions

Does metformin cause weight loss? Is “GLP 1mg” tablet a GLP-1 medicine? What are the Ozempic dose steps? Can people with type 1 diabetes take Ozempic? Is Ozempic safe?
Did this answer your question?

Sources

  1. PIB Research (Government of India). GLP-1 drugs: use, risks, and regulation. 1 Apr 2026. Key takeaways; "Regulation of GLP-1 drugs". static.pib.gov.in
  2. CDSCO. Recommendations of the Subject Expert Committee (Endocrinology & Metabolism): 20–21 Apr 2023, item 1, tirzepatide (cdsco.gov.in · archived copy); 13–14 Feb 2024, items 3–4, semaglutide (cdsco.gov.in · archived copy).
  3. Novo Nordisk. Ozempic (semaglutide) US prescribing information, revised 05/2026. Sections 4, 5.2, 5.6, 6.1, 7.1, 7.2, 12.3 (Figure 4), 14.1. US label, not the Indian one: we found no public Indian label. novo-pi.com
  4. Ahrén B et al. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2). Lancet Diabetes Endocrinol 2017;5(5):341-354. Funded by Novo Nordisk. doi:10.1016/S2213-8587(17)30092-X · PMID 28385659
  5. Laurus Labs. Metformin hydrochloride tablets, US prescribing information (DailyMed), revised 7/2026. Sections 5.1, 5.2, 5.3, 6.1 (Table 1) and Medication Guide. US label, not an Indian one. dailymed.nlm.nih.gov
  6. Makkar BM, Kumar CV, Saboo B, Agarwal S, on behalf of the RSSDI 2022 Consensus Group. RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2022. Int J Diabetes Dev Ctries 2022;42(Suppl 1):1-143. Pharmacological management: metformin and GLP-1 analogue recommendations. doi:10.1007/s13410-022-01129-5 · full text (PDF)
  7. American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes—2026. Diabetes Care 2026;49(Suppl 1):S183-S215. Table 9.2 (metformin). doi:10.2337/dc26-S009 · PMID 41358900. pmc.ncbi.nlm.nih.gov
  8. American Diabetes Association Professional Practice Committee. 3. Prevention or delay of diabetes and associated comorbidities: Standards of Care in Diabetes—2026. Diabetes Care 2026;49(Suppl 1):S50-S60. Recommendation 3.10 and text. doi:10.2337/dc26-S003 · PMID 41358891. pmc.ncbi.nlm.nih.gov
  9. American Diabetes Association. Severe hypoglycemia (severe low blood glucose). diabetes.org

Last checked 5 Oct 2026 · Next review due 5 Oct 2027 · Report an error

How this answer was made. Written by the GLP Guidebook team from the sources above. It's general information, not medical advice. Talk to a qualified doctor before starting, stopping or changing any medicine. How we write